Mansoor Karimifar
1*1 Department of Rheumatology, Isfahan University of Medical Sciences, Isfahan, Iran
*Corresponding Author: Corresponding author: Mansoor Karimifar, Department of Rheumatology, Isfahan University of Medical Sciences, Isfahan, Iran., Email:
Mansoor_karimifar@yahoo.com
Abstract
Implication for health policy/practice/research/medical education
In cases of refractory thrombotic thrombocytopenic purpura use of rituximab is appropriate.